Broadwood Capital Trims Its Stake in Questcor Pharmaceuticals Inc (QCOR)

Neal C. Bradsher's Broadwood Capital has trimmed its stake in Questcor Pharmaceuticals Inc (NASDAQ:QCOR) by selling 20,000 shares. According to the filing with the SEC, Broadwood disposed the securities in one deal at a price of $65 per share. Following the transaction, the fund still owns around 2.78 million shares. The stake currently amasses around 4.5% of the company's stock. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) Overall, Broadwood Capital reduced significantly its position in biopharmaceutical company Questcor Pharmaceuticals Inc (NASDAQ:QCOR). In its latest 13F, the fund revealed holding almost 3.3 million shares of the company. Palo Alto Investors, led by William Leland Edwards, is another investor with a $38.05 million stake, which contains around 656,000 shares of the company. Christopher R. Hansen's Valiant Capital disclosed holding 531,600 shares in its latest 13F. Questcor Pharmaceuticals Inc (NASDAQ:QCOR)'s stock returned almost 30% over the past six months, trailing a P/E of 14.8x. A couple of days ago, the company paid a quarterly dividend of $0.30 per share. Last month, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) announced that it has repurchased around 500,000 shares of its common stock at an average price of $57.21 apiece. Broadwood Capital is a mid-sized New York City-based fund with an equity portfolio worth around $468.5 million. At the beginning of the month, the fund disclosed raising its stake in BioTime, Inc. (NYSEMKT:BTX) to 9.52 million shares, from some 9.02 million held previosly. Overall, the stake currently amasses 14.1% of BioTime's outstanding stock. Among the largest stakes revealed by Broadwood in its latest 13F, is STAAR Surgical Company (NASDAQ:STAA), in which the fund holds a $86.68 million stake, which amasses 6.4 million shares. Another one is Monster Beverage Corp (NASDAQ:MNST), in which Broadwood owns 1.61 million shares, worth $84.08 million. Disclosure: none Recommended Reading: Hedge Fund News: Rob Citrone, David Tepper & Paul Singer Hedge Fund Highlights: Steven Cohen, Barry Rosenstein & George Soros Corvex Capital Is Going Long Signet Jewelers Ltd. (SIG)
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 30 percentage points in 13 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!